141 related articles for article (PubMed ID: 32320856)
1. miR-296-5p suppresses stem cell potency of hepatocellular carcinoma cells via regulating Brg1/Sall4 axis.
Shi DM; Shi XL; Xing KL; Zhou HX; Lu LL; Wu WZ
Cell Signal; 2020 Aug; 72():109650. PubMed ID: 32320856
[TBL] [Abstract][Full Text] [Related]
2. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
3. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling.
Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ
J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894
[TBL] [Abstract][Full Text] [Related]
4. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
[TBL] [Abstract][Full Text] [Related]
5. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
Fan H; Cui Z; Zhang H; Mani SK; Diab A; Lefrancois L; Fares N; Merle P; Andrisani O
Oncogene; 2017 Apr; 36(17):2435-2445. PubMed ID: 27797380
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
7. miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signaling.
Liu Y; Liu DL; Dong LL; Wen D; Shi DM; Zhou J; Fan J; Wu WZ
Cell Death Dis; 2016 Sep; 7(9):e2377. PubMed ID: 27685621
[TBL] [Abstract][Full Text] [Related]
8. miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.
Gu Y; Wei X; Sun Y; Gao H; Zheng X; Wong LL; Jin L; Liu N; Hernandez B; Peplowska K; Zhao X; Zhan QM; Feng XH; Tang ZY; Ji J
Cancer Res; 2019 Mar; 79(5):941-953. PubMed ID: 30530815
[TBL] [Abstract][Full Text] [Related]
9. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
Qiu G; Lin Y; Zhang H; Wu D
Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling.
Long J; Jiang C; Liu B; Dai Q; Hua R; Chen C; Zhang B; Li H
Cancer Lett; 2018 Jun; 423():113-126. PubMed ID: 29196128
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
12. Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma.
Gu Y; Ji F; Liu N; Zhao Y; Wei X; Hu S; Jia W; Wang XW; Budhu A; Ji J; Zhao B; Roessler S; Zheng X; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):268. PubMed ID: 33256802
[TBL] [Abstract][Full Text] [Related]
13. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
15. Extract of Stellerachamaejasme L(ESC) inhibits growth and metastasis of human hepatocellular carcinoma via regulating microRNA expression.
Liu X; Wang S; Xu J; Kou B; Chen D; Wang Y; Zhu X
BMC Complement Altern Med; 2018 Mar; 18(1):99. PubMed ID: 29554896
[TBL] [Abstract][Full Text] [Related]
16. microRNA-4270-5p inhibits cancer cell proliferation and metastasis in hepatocellular carcinoma by targeting SATB2.
Wang Y; Li CF; Sun LB; Li YC
Hum Cell; 2020 Oct; 33(4):1155-1164. PubMed ID: 32504285
[TBL] [Abstract][Full Text] [Related]
17. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
Sun X; Liu Y; Li M; Wang M; Wang Y
Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
[TBL] [Abstract][Full Text] [Related]
18. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
Zhao J; Xu T; Wang F; Cai W; Chen L
Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
[TBL] [Abstract][Full Text] [Related]
20. miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression.
Chen M; Wu L; Tu J; Zhao Z; Fan X; Mao J; Weng Q; Wu X; Huang L; Xu M; Ji J
EBioMedicine; 2018 Sep; 35():142-154. PubMed ID: 30111512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]